Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Market Professional Survey Report 2019

Published Date : 2019-09-12

Published By : Qy Research

Category : Pharma & Healthcare

No. of Pages : 114

DTaP (also DTPa and TDaP) is a combined vaccine against diphtheria, tetanus, and pertussis, in which the pertussis component is acellular. This is in contrast to whole-cell, inactivated DTP (aka DTwP). The acellular vaccine uses selected antigens of the pertussis pathogen to induce immunity. Because it uses fewer antigens than the whole cell vaccines, it is considered safer, but it is also more expensive. Recent research suggests that the DTP vaccine is more effective than DTaP in conferring immunity; this is because DTaP's narrower antigen base is less effective against current pathogen strains.

The global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine market was valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
This report focuses on Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine volume and value at global level, regional level and company level. From a global perspective, this report represents overall Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.

The following manufacturers are covered:
Sanofi Pasteur
GlaxoSmithKline
Protein Sciences Corporation
Novartis AG
Seqirus
Merck Sharp & Dohme Corp
Astellas Pharma US, Inc
Pfizer Inc
Johnson & Johnson
Lanzhou Institute of Biological Products Co., Ltd
AstraZeneca
Emergent BioSolutions Inc

Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India

Segment by Type
Immune DTaP Vaccine
Therapy DTaP Vaccine

Segment by Application
Adult
Pediatric

Table of Contents

Executive Summary
1 Industry Overview of Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine
1.1 Definition of Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine
1.2 Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Segment by Type
1.2.1 Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Production Growth Rate Comparison by Types (2014-2025)
1.2.2 Immune DTaP Vaccine
1.2.3 Therapy DTaP Vaccine
1.3 Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Segment by Applications
1.3.1 Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Consumption Comparison by Applications (2014-2025)
1.3.2 Adult
1.3.3 Pediatric
1.4 Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Overall Market
1.4.1 Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue (2014-2025)
1.4.2 Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Production (2014-2025)
1.4.3 North America Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Status and Prospect (2014-2025)
1.4.4 Europe Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Status and Prospect (2014-2025)
1.4.5 China Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Status and Prospect (2014-2025)
1.4.6 Japan Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Status and Prospect (2014-2025)
1.4.7 Southeast Asia Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Status and Prospect (2014-2025)
1.4.8 India Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Status and Prospect (2014-2025)

2 Manufacturing Cost Structure Analysis
2.1 Raw Material and Suppliers
2.2 Manufacturing Cost Structure Analysis of Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine
2.3 Manufacturing Process Analysis of Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine
2.4 Industry Chain Structure of Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine

3 Development and Manufacturing Plants Analysis of Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine
3.1 Capacity and Commercial Production Date
3.2 Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Manufacturing Plants Distribution
3.3 Major Manufacturers Technology Source and Market Position of Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine
3.4 Recent Development and Expansion Plans

4 Key Figures of Major Manufacturers
4.1 Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Production and Capacity Analysis
4.2 Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue Analysis
4.3 Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Price Analysis
4.4 Market Concentration Degree

5 Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Regional Market Analysis
5.1 Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Production by Regions
5.1.1 Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Production by Regions
5.1.2 Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue by Regions
5.2 Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Consumption by Regions
5.3 North America Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Market Analysis
5.3.1 North America Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Production
5.3.2 North America Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue
5.3.3 Key Manufacturers in North America
5.3.4 North America Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Import and Export
5.4 Europe Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Market Analysis
5.4.1 Europe Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Production
5.4.2 Europe Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue
5.4.3 Key Manufacturers in Europe
5.4.4 Europe Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Import and Export
5.5 China Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Market Analysis
5.5.1 China Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Production
5.5.2 China Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue
5.5.3 Key Manufacturers in China
5.5.4 China Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Import and Export
5.6 Japan Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Market Analysis
5.6.1 Japan Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Production
5.6.2 Japan Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue
5.6.3 Key Manufacturers in Japan
5.6.4 Japan Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Import and Export
5.7 Southeast Asia Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Market Analysis
5.7.1 Southeast Asia Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Production
5.7.2 Southeast Asia Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue
5.7.3 Key Manufacturers in Southeast Asia
5.7.4 Southeast Asia Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Import and Export
5.8 India Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Market Analysis
5.8.1 India Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Production
5.8.2 India Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue
5.8.3 Key Manufacturers in India
5.8.4 India Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Import and Export

6 Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Segment Market Analysis (by Type)
6.1 Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Production by Type
6.2 Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue by Type
6.3 Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Price by Type

7 Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Segment Market Analysis (by Application)
7.1 Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Consumption by Application
7.2 Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Consumption Market Share by Application (2014-2019)

8 Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Major Manufacturers Analysis
8.1 Sanofi Pasteur
8.1.1 Sanofi Pasteur Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Production Sites and Area Served
8.1.2 Sanofi Pasteur Product Introduction, Application and Specification
8.1.3 Sanofi Pasteur Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.1.4 Main Business and Markets Served
8.2 GlaxoSmithKline
8.2.1 GlaxoSmithKline Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Production Sites and Area Served
8.2.2 GlaxoSmithKline Product Introduction, Application and Specification
8.2.3 GlaxoSmithKline Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.2.4 Main Business and Markets Served
8.3 Protein Sciences Corporation
8.3.1 Protein Sciences Corporation Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Production Sites and Area Served
8.3.2 Protein Sciences Corporation Product Introduction, Application and Specification
8.3.3 Protein Sciences Corporation Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.3.4 Main Business and Markets Served
8.4 Novartis AG
8.4.1 Novartis AG Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Production Sites and Area Served
8.4.2 Novartis AG Product Introduction, Application and Specification
8.4.3 Novartis AG Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.4.4 Main Business and Markets Served
8.5 Seqirus
8.5.1 Seqirus Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Production Sites and Area Served
8.5.2 Seqirus Product Introduction, Application and Specification
8.5.3 Seqirus Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.5.4 Main Business and Markets Served
8.6 Merck Sharp & Dohme Corp
8.6.1 Merck Sharp & Dohme Corp Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Production Sites and Area Served
8.6.2 Merck Sharp & Dohme Corp Product Introduction, Application and Specification
8.6.3 Merck Sharp & Dohme Corp Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.6.4 Main Business and Markets Served
8.7 Astellas Pharma US, Inc
8.7.1 Astellas Pharma US, Inc Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Production Sites and Area Served
8.7.2 Astellas Pharma US, Inc Product Introduction, Application and Specification
8.7.3 Astellas Pharma US, Inc Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.7.4 Main Business and Markets Served
8.8 Pfizer Inc
8.8.1 Pfizer Inc Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Production Sites and Area Served
8.8.2 Pfizer Inc Product Introduction, Application and Specification
8.8.3 Pfizer Inc Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.8.4 Main Business and Markets Served
8.9 Johnson & Johnson
8.9.1 Johnson & Johnson Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Production Sites and Area Served
8.9.2 Johnson & Johnson Product Introduction, Application and Specification
8.9.3 Johnson & Johnson Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.9.4 Main Business and Markets Served
8.10 Lanzhou Institute of Biological Products Co., Ltd
8.10.1 Lanzhou Institute of Biological Products Co., Ltd Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Production Sites and Area Served
8.10.2 Lanzhou Institute of Biological Products Co., Ltd Product Introduction, Application and Specification
8.10.3 Lanzhou Institute of Biological Products Co., Ltd Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.10.4 Main Business and Markets Served
8.11 AstraZeneca
8.12 Emergent BioSolutions Inc

9 Development Trend of Analysis of Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Market
9.1 Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Market Trend Analysis
9.1.1 Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Market Size (Volume and Value) Forecast 2019-2025
9.2 Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Regional Market Trend
9.2.1 North America Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Forecast 2019-2025
9.2.2 Europe Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Forecast 2019-2025
9.2.3 China Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Forecast 2019-2025
9.2.4 Japan Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Forecast 2019-2025
9.2.5 Southeast Asia Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Forecast 2019-2025
9.2.6 India Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Forecast 2019-2025
9.3 Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Market Trend (Product Type)
9.4 Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Market Trend (Application)

10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.3 Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Customers

11 Market Dynamics
11.1 Market Trends
11.2 Opportunities
11.3 Market Drivers
11.4 Challenges
11.5 Influence Factors

12 Conclusion
13 Appendix
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Author List
13.4 Disclaimer


List of Tables and Figures
Figure Picture of Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine
Table Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Production (K Doses) Growth Rate Comparison by Types (2014-2025)
Figure Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Production Market Share by Types in 2018
Figure Immune DTaP Vaccine Product Picture
Figure Therapy DTaP Vaccine Product Picture
Table Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Consumption (K Doses) Comparison by Applications (2014-2025)
Figure Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Consumption Market Share by Applications in 2018
Figure Adult
Figure Pediatric
Figure Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue (Million USD) (2014-2025)
Figure Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Production (K Doses) (2014-2025)
Figure North America Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Market Size (Million USD) (2014-2025)
Figure Europe Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Market Size (Million USD) (2014-2025)
Figure China Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Market Size (Million USD) (2014-2025)
Figure Japan Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Market Size (Million USD) (2014-2025)
Figure Southeast Asia Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Market Size (Million USD) (2014-2025)
Figure India Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Market Size (Million USD) (2014-2025)
Table Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Raw Material and Suppliers
Table Manufacturing Cost Structure Analysis of Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine in 2018
Figure Manufacturing Process Analysis of Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine
Figure Industry Chain Structure of Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine
Table Capacity and Commercial Production Date of Key Manufacturers
Table Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Manufacturing Plants Distribution
Table Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Major Manufacturers Technology Source and Market Position
Table Recent Development and Expansion Plans in Future
Table Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Capacity (K Doses) of Major Manufacturers (2014-2019)
Table Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Production (K Doses) of Major Manufacturers (2014-2019)
Table Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Production Market Share of Major Manufacturers (2014-2019)
Figure Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Production Share by Manufacturers in 2018
Table Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue (Million US$) of Major Manufacturers (2014-2019)
Table Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue Market Share of Major Manufacturers (2014-2019)
Figure Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue Share by Manufacturers in 2018
Table Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Average Price (USD/Dose) of Major Manufacturers (2014-2019)
Table Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Production by Regions 2014-2019 (K Doses)
Table Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Production Market Share by Regions 2014-2019
Figure Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Production Market Share by Regions in 2018
Table Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue by Regions 2014-2019 (Million USD)
Table Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue Market Share by Regions 2014-2019
Figure Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue Market Share by Regions in 2018
Table Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Consumption by Regions 2014-2019 (K Doses)
Table Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Consumption Market Share by Regions 2014-2019
Figure North America Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Production Growth Rate 2014-2019 (K Doses)
Figure North America Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue Growth Rate 2014-2019 (Million USD)
Table North America Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Production, Consumption Import and Export (K Doses)
Figure Europe Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Production Growth Rate 2014-2019 (K Doses)
Figure Europe Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue Growth Rate 2014-2019 (Million USD)
Table Europe Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Production, Consumption Import and Export (K Doses)
Figure China Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Production Growth Rate 2014-2019 (K Doses)
Figure China Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue Growth Rate 2014-2019 (Million USD)
Table China Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Production, Consumption Import and Export (K Doses)
Figure Japan Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Production Growth Rate 2014-2019 (K Doses)
Figure Japan Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue Growth Rate 2014-2019 (Million USD)
Table Japan Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Production, Consumption Import and Export (K Doses)
Figure Southeast Asia Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Production Growth Rate 2014-2019 (K Doses)
Figure Southeast Asia Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue Growth Rate 2014-2019 (Million USD)
Table Southeast Asia Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Production, Consumption Import and Export (K Doses)
Figure India Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Production Growth Rate 2014-2019 (K Doses)
Figure India Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue Growth Rate 2014-2019 (Million USD)
Table India Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Production, Consumption Import and Export (K Doses)
Figure Global Consumption Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Market Share by Application (2014-2019)
Figure Global Value (Consumption) Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Market Share by Application (2014-2019)
Table Sanofi Pasteur Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Production Sites and Area Served
Table Sanofi Pasteur Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Product Introduction, Application and Specification
Table Sanofi Pasteur Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Production (K Doses), Revenue (Million USD), Ex-factory Price (USD/Dose) and Gross Margin (2014-2019)
Table Sanofi Pasteur Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Production Growth Rate (2014-2019)
Table Sanofi Pasteur Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Production Market Share (2014-2019)
Figure Sanofi Pasteur Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue Market Share (2014-2019)
Table Sanofi Pasteur Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Main Business and Markets Served
Table GlaxoSmithKline Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Production Sites and Area Served
Table GlaxoSmithKline Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Product Introduction, Application and Specification
Table GlaxoSmithKline Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Production (K Doses), Revenue (Million USD), Ex-factory Price (USD/Dose) and Gross Margin (2014-2019)
Table GlaxoSmithKline Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Production Growth Rate (2014-2019)
Table GlaxoSmithKline Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Production Market Share (2014-2019)
Figure GlaxoSmithKline Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue Market Share (2014-2019)
Table GlaxoSmithKline Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Main Business and Markets Served
Table Protein Sciences Corporation Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Production Sites and Area Served
Table Protein Sciences Corporation Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Product Introduction, Application and Specification
Table Protein Sciences Corporation Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Production (K Doses), Revenue (Million USD), Ex-factory Price (USD/Dose) and Gross Margin (2014-2019)
Table Protein Sciences Corporation Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Production Growth Rate (2014-2019)
Table Protein Sciences Corporation Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Production Market Share (2014-2019)
Figure Protein Sciences Corporation Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue Market Share (2014-2019)
Table Protein Sciences Corporation Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Main Business and Markets Served
Table Novartis AG Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Production Sites and Area Served
Table Novartis AG Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Product Introduction, Application and Specification
Table Novartis AG Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Production (K Doses), Revenue (Million USD), Ex-factory Price (USD/Dose) and Gross Margin (2014-2019)
Table Novartis AG Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Production Growth Rate (2014-2019)
Table Novartis AG Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Production Market Share (2014-2019)
Figure Novartis AG Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue Market Share (2014-2019)
Table Novartis AG Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Main Business and Markets Served
Table Seqirus Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Production Sites and Area Served
Table Seqirus Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Product Introduction, Application and Specification
Table Seqirus Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Production (K Doses), Revenue (Million USD), Ex-factory Price (USD/Dose) and Gross Margin (2014-2019)
Table Seqirus Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Production Growth Rate (2014-2019)
Table Seqirus Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Production Market Share (2014-2019)
Figure Seqirus Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue Market Share (2014-2019)
Table Seqirus Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Main Business and Markets Served
Table Merck Sharp & Dohme Corp Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Production Sites and Area Served
Table Merck Sharp & Dohme Corp Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Product Introduction, Application and Specification
Table Merck Sharp & Dohme Corp Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Production (K Doses), Revenue (Million USD), Ex-factory Price (USD/Dose) and Gross Margin (2014-2019)
Table Merck Sharp & Dohme Corp Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Production Growth Rate (2014-2019)
Table Merck Sharp & Dohme Corp Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Production Market Share (2014-2019)
Figure Merck Sharp & Dohme Corp Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue Market Share (2014-2019)
Table Merck Sharp & Dohme Corp Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Main Business and Markets Served
Table Astellas Pharma US, Inc Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Production Sites and Area Served
Table Astellas Pharma US, Inc Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Product Introduction, Application and Specification
Table Astellas Pharma US, Inc Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Production (K Doses), Revenue (Million USD), Ex-factory Price (USD/Dose) and Gross Margin (2014-2019)
Table Astellas Pharma US, Inc Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Production Growth Rate (2014-2019)
Table Astellas Pharma US, Inc Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Production Market Share (2014-2019)
Figure Astellas Pharma US, Inc Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue Market Share (2014-2019)
Table Astellas Pharma US, Inc Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Main Business and Markets Served
Table Pfizer Inc Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Production Sites and Area Served
Table Pfizer Inc Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Product Introduction, Application and Specification
Table Pfizer Inc Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Production (K Doses), Revenue (Million USD), Ex-factory Price (USD/Dose) and Gross Margin (2014-2019)
Table Pfizer Inc Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Production Growth Rate (2014-2019)
Table Pfizer Inc Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Production Market Share (2014-2019)
Figure Pfizer Inc Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue Market Share (2014-2019)
Table Pfizer Inc Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Main Business and Markets Served
Table Johnson & Johnson Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Production Sites and Area Served
Table Johnson & Johnson Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Product Introduction, Application and Specification
Table Johnson & Johnson Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Production (K Doses), Revenue (Million USD), Ex-factory Price (USD/Dose) and Gross Margin (2014-2019)
Table Johnson & Johnson Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Production Growth Rate (2014-2019)
Table Johnson & Johnson Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Production Market Share (2014-2019)
Figure Johnson & Johnson Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue Market Share (2014-2019)
Table Johnson & Johnson Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Main Business and Markets Served
Table Lanzhou Institute of Biological Products Co., Ltd Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Production Sites and Area Served
Table Lanzhou Institute of Biological Products Co., Ltd Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Product Introduction, Application and Specification
Table Lanzhou Institute of Biological Products Co., Ltd Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Production (K Doses), Revenue (Million USD), Ex-factory Price (USD/Dose) and Gross Margin (2014-2019)
Table Lanzhou Institute of Biological Products Co., Ltd Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Production Growth Rate (2014-2019)
Table Lanzhou Institute of Biological Products Co., Ltd Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Production Market Share (2014-2019)
Figure Lanzhou Institute of Biological Products Co., Ltd Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue Market Share (2014-2019)
Table Lanzhou Institute of Biological Products Co., Ltd Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Main Business and Markets Served
Table AstraZeneca Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Production Sites and Area Served
Table Emergent BioSolutions Inc Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Production Sites and Area Served
Figure Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Production (K Doses) Growth Rate Forecast 2019-2025
Figure Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue (Million USD) Growth Rate Forecast 2019-2025
Figure Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Sales Price (USD/Dose) Forecast 2019-2025
Figure North America Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Production Growth Rate Forecast 2019-2025 (K Doses)
Figure North America Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Europe Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Production Growth Rate Forecast 2019-2025 (K Doses)
Figure Europe Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure China Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Production Growth Rate Forecast 2019-2025 (K Doses)
Figure China Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Japan Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Production Growth Rate Forecast 2019-2025 (K Doses)
Figure Japan Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Southeast Asia Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Production Growth Rate Forecast 2019-2025 (K Doses)
Figure Southeast Asia Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure India Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Production Growth Rate Forecast 2019-2025 (K Doses)
Figure India Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Revenue Growth Rate Forecast 2019-2025 (Million USD)
Table Global Production (K Doses) of Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine by Type (2019-2025)
Table Global Consumption (K Doses) of Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine by Application (2019-2025)
Table Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Distributors List
Table Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Customers List
Table Market Key Trends
Table Key Opportunities
Table Market Key Drivers
Table Key Challenges
Table Key Influence Factors
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine  Research Assistance Research Assistance

We will be happy to help you find what you need. Please write to us:

+1-888-248-7621

sales@researchreportcenter.com